Jun 30, 2026
15 MIN READ

What Dose of Ozempic Causes Weight Loss?

Semaglutide weight loss typically begins at doses of 0.25 mg weekly, with meaningful results appearing around 2.4 mg. PlexusDx explains how dosing works and why your dose may increase while your price stays flat.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 30, 2026
15 MIN READ

what dose of ozempic causes weight loss? — PlexusDx GLP-1 education

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that signals your brain to reduce hunger and slow stomach emptying, making weight loss possible at relatively low starting doses. Clinical trials show that even modest initial doses can trigger measurable appetite suppression, though higher therapeutic doses (2.4 mg weekly) produce the most significant weight reduction. Understanding how semaglutide dosing works helps set realistic expectations for your weight loss timeline.

How Semaglutide Dosing Starts and Escalates

Semaglutide treatment begins with a 0.25 mg injection once weekly, a microdose designed to minimize nausea while your body adjusts to GLP-1 signaling. This opening dose activates GLP-1 receptors in your brain and gut, but weight loss at this level is typically modest—most patients notice appetite reduction rather than dramatic scale drops. Over 4 weeks, your dose increases by 0.25 mg increments: 0.5 mg in week 5, 0.75 mg in week 9, and so on, with many patients reaching 2.4 mg by month 4 or later.

Your prescriber may pause dose escalation if you experience side effects, or advance more slowly based on your clinical response and tolerability. PlexusDx compounded semaglutide injections are available at a flat monthly rate regardless of your current dose level, meaning your price won't climb as your therapeutic dose increases. This pricing model removes a barrier to safe, gradual dosing that many patients actually need for best results and lowest side-effect burden.

Minimum Dose for Weight Loss: What the Evidence Shows

Research demonstrates that weight loss begins at semaglutide doses as low as 0.5 mg weekly, though the magnitude is modest at this level—typically 2–4 pounds per month in early studies. The STEP 1 trial, which tested semaglutide for chronic weight management, found that 1 mg weekly produced average weight loss of 5.9% of baseline body weight over 68 weeks, while 2.4 mg weekly achieved 10.9% loss. This dose-response curve shows a clear relationship: higher therapeutic doses deliver greater weight reduction, but even lower doses activate the biological machinery required for appetite suppression.

Patients who experience side effects or prefer a gentler approach can maintain meaningful weight loss at 1 mg or 1.5 mg weekly, trading maximum effect for better tolerability. PlexusDx's Microdose GLP-1 Protocol at $129/month offers an alternative for those starting conservatively or managing mild nausea, while standard semaglutide injections begin at $149/month for full-dose potential.

When Does Semaglutide Weight Loss Become Noticeable?

Most patients report appetite reduction within days to weeks of starting semaglutide, even at 0.25 mg, but measurable weight loss on the scale typically appears between weeks 4 and 8 as doses escalate toward therapeutic ranges. By 12 weeks (around 1 mg or higher), the majority of patients in clinical trials saw 3–5% weight loss relative to their starting weight. Full therapeutic benefit at 2.4 mg usually requires 16–20 weeks of consistent injections, at which point monthly weight loss often plateaus or slows—a normal and expected response as your body reaches a new energy balance.

Individual timelines vary widely based on baseline metabolism, diet, activity level, and genetic predisposition to GLP-1 signaling. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes key variants in your GLP1R and GIPR genes to reveal whether your genetic profile predicts stronger or more modest receptor sensitivity, helping your provider optimize your dose strategy and expectations from the start.

Dose Adjustments and Reaching Your Target Dose

Your semaglutide dose typically increases every 4 weeks in 0.25 mg steps unless side effects warrant a slower pace or your clinical response is already excellent at a lower dose. Reaching 2.4 mg—the standard therapeutic endpoint in weight loss trials—usually takes 4–5 months with standard titration. Some patients find their sweet spot at 1.5 mg or 2 mg and choose to stay there, achieving 7–9% weight loss without pursuing further escalation, and PlexusDx supports this individualized approach without penalty.

If nausea, constipation, or other side effects emerge, your prescriber may pause or extend the interval between dose increases, allowing your body time to adapt. Because PlexusDx charges a flat monthly rate for semaglutide injection—never a per-dose fee—you can titrate at whatever pace your body tolerates without worrying that slower dosing will cost more. This pricing model aligns your treatment with science-based, gradual escalation rather than rushing to high doses to 'get your money's worth.'

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What dose of semaglutide do I need to lose weight?

Weight loss can begin as low as 0.5 mg weekly, but the most robust results appear at 2.4 mg weekly based on clinical trials. Most patients start at 0.25 mg and escalate gradually over 4–5 months. PlexusDx compounded semaglutide injections start at $149/month regardless of your current dose, so your price remains flat as your treatment advances.

How much weight can I lose on semaglutide at different doses?

The STEP 1 trial found average weight loss of 5.9% at 1 mg weekly and 10.9% at 2.4 mg weekly over 68 weeks. Individual results vary based on diet, activity, and genetics, but the trend is clear: higher doses generally yield greater total weight loss. Your actual outcome also depends on your baseline metabolism and adherence to lifestyle changes.

Does PlexusDx offer compounded semaglutide at all dose levels?

Yes. PlexusDx compounded semaglutide injections are available from licensed 503A pharmacies and cover the full dose range from 0.25 mg to 2.4 mg weekly at a flat rate starting at $149/month. No membership or insurance is required, and the medication is HSA/FSA eligible.

Is it safe to stay on a lower semaglutide dose if I'm getting results?

Yes. Many patients achieve meaningful weight loss at 1 mg, 1.5 mg, or 2 mg weekly and choose not to escalate further—this is a valid clinical decision if you're satisfied with your progress and side-effect profile. Your prescriber can help you decide whether a lower maintenance dose meets your goals.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes variants in your GLP1R and GIPR genes to reveal your genetic predisposition to GLP-1 receptor sensitivity. This insight helps your provider predict whether you'll respond robustly at standard doses or may need personalized titration, improving your likelihood of success and tolerability.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves